CRA is a proud sponsor of this event.
Sean Durkin is speaking during the webinar to discuss the current and emerging state and federal antitrust class certification rules and provisions to obviate the likelihood of non-compliance hurdles.
For more information on this event, click here.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...